Chromatin-modifying enzymes essential for hematopoiesis
Enzyme . | Epigenetic activity . | Targeting strategy . | Role in HSC self-renewal . | Lineage-specific role . | Ref no. . |
---|---|---|---|---|---|
Moz | Histone acetylation | KO | Yes | No | 55 |
KO | Yes | Myeloid | 56 | ||
Mll1 | Histone methylation | KO | Yes | Myeloid | 67 |
KO | Yes | No | 68 | ||
CKO; Mx1-Cre,lysozyme M-Cre,CD19-Cre, lck-Cre | Yes | No | 69 | ||
Ezh2 | Histone methylation | CKO; Mx1-Cre | — | Lymphoid | 75 |
CKO; Tie2-Cre,Rosa26-Cre | No | Erythroid and lymphoid | 74 | ||
Dot1L | Histone methylation | Inducible KO;Rosa26-Cre-ER | Yes | MPPs and myeloid | 91 |
Inducible KO;Rosa26-Cre-ER | Yes | MPPs and myeloid | 90 | ||
KO | — | Erythroid | 89 | ||
Lsd1 | Histone demethylation | CKD; global | Yes | Myeloid | 99 |
Dnmt1 | DNA 5mC | CKO; Mx1-Cre | Yes | Myeloid | 26 |
CKO; Mx1-CreHypomorph | Yes | Lymphoid | 27 | ||
Dnmt3a | DNA 5mC | CKO; Mx1-Cre | Yes | Long-term HSCs | 29 |
Tet2 | DNA 5hmC | KO | Yes | Myeloid | 37 |
KO | Yes | Myeloid | 36 | ||
CKO; Vav-Cre,Ella-Cre, Mx1-Cre | Yes | Myeloid | 38 | ||
KOCKO; Mx1-Cre | Yes | Lymphoid and myeloid | 39 |
Enzyme . | Epigenetic activity . | Targeting strategy . | Role in HSC self-renewal . | Lineage-specific role . | Ref no. . |
---|---|---|---|---|---|
Moz | Histone acetylation | KO | Yes | No | 55 |
KO | Yes | Myeloid | 56 | ||
Mll1 | Histone methylation | KO | Yes | Myeloid | 67 |
KO | Yes | No | 68 | ||
CKO; Mx1-Cre,lysozyme M-Cre,CD19-Cre, lck-Cre | Yes | No | 69 | ||
Ezh2 | Histone methylation | CKO; Mx1-Cre | — | Lymphoid | 75 |
CKO; Tie2-Cre,Rosa26-Cre | No | Erythroid and lymphoid | 74 | ||
Dot1L | Histone methylation | Inducible KO;Rosa26-Cre-ER | Yes | MPPs and myeloid | 91 |
Inducible KO;Rosa26-Cre-ER | Yes | MPPs and myeloid | 90 | ||
KO | — | Erythroid | 89 | ||
Lsd1 | Histone demethylation | CKD; global | Yes | Myeloid | 99 |
Dnmt1 | DNA 5mC | CKO; Mx1-Cre | Yes | Myeloid | 26 |
CKO; Mx1-CreHypomorph | Yes | Lymphoid | 27 | ||
Dnmt3a | DNA 5mC | CKO; Mx1-Cre | Yes | Long-term HSCs | 29 |
Tet2 | DNA 5hmC | KO | Yes | Myeloid | 37 |
KO | Yes | Myeloid | 36 | ||
CKO; Vav-Cre,Ella-Cre, Mx1-Cre | Yes | Myeloid | 38 | ||
KOCKO; Mx1-Cre | Yes | Lymphoid and myeloid | 39 |
CKO, conditional knockout; CKD, conditional knockdown; 5hmC, 5-hydroxymethyl cytosine; MPP, multipotent progenitor.